REFERENCES:
- Janson C, Johannessen A, Franklin K, Svanes C, Schiöler L, Malinovschi
A, Gislason T, Benediktsdottir B, Schlünssen V, Jögi R, Jarvis D,
Lindberg E. Change in the prevalence asthma, rhinitis and respiratory
symptom over a 20 year period: associations to year of birth, life
style and sleep rate symptoms. BMC Pulmonary Medicine. 2018;18:152.
- Barber D, Diaz-Perales A, Escribese MM, Kleine-Tebbe J, Matricardi PM,
Ollert M, Santos AF, Sastre J. Molecular allergology and its impact in
specific allergy diagnosis and therapy. Allergy. 2021;76:3642-3658.
- Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P et al. Guidelines
on allergen-specific immunotherapy in IgE-mediated allergic diseases
Allergo J Int 2014. 23(8):282-319.
- Sekerkova A, Polackova M, Striz I. Detection of Phl p 1, Phl p 5, Phl
p 7 and Phl p 12 specific IgE antibodies in the sera of children and
adult patients allergic to Phleum pollen. Allergol Int.
2012;61(2):339–46.
- Moingeon P, Floch VB-L, Airouche S, Baron-Bodo V, Nony E, Mascarell L.
Allergen immunotherapy for birch pollen-allergic patients: recent
advances. Immunotherapy. 2016;8(5):555–67.
- Imhof K, Probst E, Seifert B, Regenass S, Schmid-Grendelmeier P. Ash
pollen allergy: reliable detection of sensitization on the basis of
IgE to Ole e 1. Allergo J Int. 2014;23(3):78–83.
- Niederberger V, Purohit A, Oster JP, Spitzauer S, Valenta R, Pauli G.
The allergen profile of ash (Fraxinus excelsior) pollen:
cross-reactivity with allergens from various plant species. Clin. Exp.
Allergy. 2002;32:933-941.
- https://www.pollenwarndienst.at/aktuelle-belastung/pollen-jahr.html;
cited: 21-01-2022
- Lombardero M, García-Sellés FJ, Polo F, Jimeno L, Chamorro MJ,
García-Casado G, et al. Prevalence of sensitization to Artemisia
allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among
Art v 3 and other relevant lipid-transfer protein allergens. Clin Exp
Allergy 2004;34(9):1415–21.
- Gadermaier G, Wopfner N, Wallner M, Egger M, Didierlaurent A, Regl G,
et al. Array-based profiling of ragweed and mugwort pollen allergens.
Allergy. 2008;63(11):1543–9.
- Wopfner N, Gadermaier G, Egger M, Asero R, Ebner C, Jahn-Schmid B, et
al. The spectrum of allergens in ragweed and mugwort pollen. Int.
Arch. Allergy Immunol. 2005;138(4):337–46.
- Pichler U, Hauser M, Wolf M, Bernardi ML, Gadermaier et al. Pectate
lyase pollen allergens: Sensitization profiles and cross-reactivity
pattern. PloSOne 2015; 10: e 0120038
- Hartl C, Horak F. Significance of component-resolved diagnostics for
diagnosis and therapy of patients with inhalant allergies. MedUni Wien
ePub 2021;
https://repositorium.meduniwien.ac.at/obvumwhs/content/titleinfo/6184303
- Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosigno MV, Mahillo
I. How molecular diagnosis can change allergen-specific immunotherapy
prescription in a complex pollen area. Allergy 2012; 67: 709-711.
- Stringari G, Tripodi S,
Caffarelli C, Dondi A, Asero R, Di Rienzo Businco A, et al. The effect
of component-resolved diagnosis on specific immunotherapy prescription
in children with hay fever. J Allergy Clin Immunol. 2014; 134(1):
75–81.
- San Nicoló M, Högerle C,
Gellrich D, Gröger M. Relevance of Major Allergens in Weed Pollen
Allergy. Int Arch Allergy Immunol 2021; 182: 637-641.
- Stemeseder T, Hemmer W, Hawranek T, Gadermaier G. Marker allergens of
weed pollen – basic considerations and diagnostic benefits in the
clinical routine. Part 16 of the Series Molecular Allergology. Allergo
J Int 2014; 23: 174-280.